1. Home
  2. MRK

MRK

Merck & Company Inc. (new)

Logo Merck & Company Inc. (new)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Founded: 2000 Country:
United States
United States
Employees: N/A City: KENILWORTH
Market Cap: 317.2B IPO Year: N/A
Target Price: $131.08 AVG Volume (30 days): 8.3M
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield: 2.42% Dividend Payout Frequency: Quarterly
EPS: 0.14 EPS Growth: -97.55
52 Week Low/High: $99.14 - $133.10 Next Earning Date: 04-25-2024
Revenue: $60,115,000,000 Revenue Growth: 1.40%
Revenue Growth (this year): 7.24% Revenue Growth (next year): 6.45%

Share on Social Networks: